COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020
The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
The researchers created a test-on-a-chip technology that takes about 35 minutes to produce a result, and may partner with Ford to produce the chips.
Developed by researchers at Yale University, the method, called deterministic barcoding in tissue sequencing, can map thousands of genes at 10 micron resolution.
The firm's assay, dubbed MesoFind, uses an immunomagnetic capture method to identify surface antigens on mesothelioma pleural cells in a patient's blood sample.